GT Biopharma Inc. (GTBP) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for GT Biopharma Inc., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$5.51
−1.25% today
Market cap
$12M
Overall quality
—
Kronos AI 30-day
+47.0%
8 of 8 simulated paths end higher
GT Biopharma Inc. (GTBP) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $12M. It trades at $5.51, down 1.25% today. 1 analysts' average target of $3.00 implies −45.6% from today's price. Kronos AI's 30-day forecast is +47.0% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $3.00 |
| Low – high | $3.00 – $3.00 |
| Analysts | 1 |
| Upside to average | −45.6% |
Kronos AI 30-day forecast
| Expected close | $8.20 (+47.0%) |
| Likely range | +39.0% … +53.5% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.